OPRA:NASDAQOpera Limited analysis
Data as of Sep 17, 2026 - not real-time
- Latest price
- $18.41
- Risk: high
- 8/10High risk
Summary
Opera Limited is priced at $18.41, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 10.2%. RSI sits at 45.1, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $17.35 up to resistance at $20.03.
On valuation the read is undervalued — earnings multiple of 13.3 versus a 15.6 sector average, below the peer group. Analyst price targets sit 42.8% above the current price. Revenue is growing at 24.6% on a 18.5% profit margin. The 4.35% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 35.8%, a beta of 1.55 and a maximum drawdown of 42.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.
On valuation the read is undervalued — earnings multiple of 13.3 versus a 15.6 sector average, below the peer group. Analyst price targets sit 42.8% above the current price. Revenue is growing at 24.6% on a 18.5% profit margin. The 4.35% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 35.8%, a beta of 1.55 and a maximum drawdown of 42.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.
Top market events
- Opera Limited NASDAQ:OPRA shares fell 5.48% in pre-market trading after the browser and AI agent company reported...
- In August 2026, Opera Limited reported past second-quarter 2026 results showing sales of US$178.
- Revenue increased 25% year-over-year to $178.
Market outlook
Short term
< 1 yearNeutral
Model confidence3/103 out of 10
Key factors
- Trading above the 200-day average of 16.50
- MACD momentum is negative
- 30-day price change of -10.2%
Medium term
1–3 yearsPositive
Model confidence4/104 out of 10
Key factors
- P/E of 13.3 versus sector average of 15.6
- Trading above the 200-day average of 16.50
- Analyst targets imply +42.8% versus the current price
Long term
> 3 yearsPositive
Model confidence6/106 out of 10
Key factors
- P/E of 13.3 versus sector average of 15.6
- Analyst targets imply +42.8% versus the current price
- Profit margin of 18.5% is healthy
Key metrics
Financial health
Revenue Growth24.60%
Profit Margin18.55%
P/E Ratio13.3
ROE12.86%
ROA6.22%
Debt/Equity0.79
P/B Ratio1.6
Op. Cash Flow$133.0M
Free Cash Flow$111.7M
Industry P/E15.6
Technical analysis
TrendNeutral
RSI45.1
Support$17.35
Resistance$20.03
MA 20$18.67
MA 50$19.16
MA 200$16.50
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Fair Value$42.82
Target Price$26.29
Upside/Downside42.78%
GradeUndervalued
TypeBlend
Dividend Yield4.35%
Risk assessment
Beta1.55
Volatility35.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.